Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation.

Saved in:
Bibliographic Details
Title: Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation.
Authors: Cheng A; College of Pharmaceutical Sciences, Southwest University, 400715 Chongqing, China.; Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578 Miyagi, Japan.; Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578 Miyagi, Japan., Kawahata I; Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578 Miyagi, Japan., Wang Y; Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578 Miyagi, Japan., Jia W; Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578 Miyagi, Japan.; Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578 Miyagi, Japan., Wang H; Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578 Miyagi, Japan., Sekimori T; Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578 Miyagi, Japan., Chen Y; Department of Industrial Engineering & Decision Analytics, Hong Kong University of Science and Technology, 999077 Hong Kong, China., Suzuki H; Department of Pathology and Laboratory Medicine, National Hospital Organization Sendai Medical Center, 983-0045 Miyagi, Japan., Takeda A; Department of Neurology, National Hospital Organization Sendai Nishitaga Hospital, 982-0805 Miyagi, Japan., Stefanova N; Laboratory for Translational Neurodegeneration Research, Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Finkelstein DI; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville VIC 3010, Australia., Ma W; School of Pharmacy, Chengdu University, 610106 Chengdu, China., Chen M; College of Pharmaceutical Sciences, Southwest University, 400715 Chongqing, China., Sasaki T; Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578 Miyagi, Japan., Fukunaga K; Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, 980-8578 Miyagi, Japan.
Source: Brain : a journal of neurology [Brain] 2023 Aug 01; Vol. 146 (8), pp. 3172-3180.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1460-2156
DOI:10.1093/brain/awad137